Report cover image

Global Pharmaceutical Market Size Study, by Molecule Type, Product, Type, Disease, Age Group, Route of Administration, Distribution Channel, and Regional Forecasts 2022-2032

Publisher Bizwit Research & Consulting
Published Mar 15, 2025
Length 285 Pages
SKU # BIZW19841842

Description

The Global Pharmaceutical Market was valued at approximately USD 1550.84 billion in 2023 and is anticipated to expand at a CAGR of 6.12% over the forecast period 2024-2032. Fueled by rapid advancements in biotechnology, increasing investments in drug development, and the rising prevalence of chronic diseases, the pharmaceutical industry is evolving at an unprecedented pace. The demand for innovative therapies, personalized medicine, and biologics continues to push the boundaries of pharmaceutical research, leading to significant breakthroughs in treatment options. Additionally, the integration of artificial intelligence (AI) and machine learning in drug discovery is expediting the development of novel therapeutics, reducing time-to-market, and enhancing precision in targeted therapies.

The surge in healthcare spending, driven by an aging population and an escalating burden of lifestyle-related disorders, has created a fertile ground for market expansion. Governments and private sector entities are heavily investing in research and development, focusing on precision medicine, rare disease treatment, and biosimilars. The growing emphasis on regulatory compliance, coupled with streamlined approval pathways for innovative drugs, is accelerating pharmaceutical product launches. However, stringent regulations, high drug development costs, and increasing pricing pressures from healthcare payers and government bodies pose significant challenges to market growth.

The North American pharmaceutical market continues to dominate, underpinned by robust R&D infrastructure, a well-established healthcare system, and strong regulatory frameworks that promote innovation. The United States remains the key revenue contributor, supported by substantial investments in biotechnology, gene therapy, and immunotherapy. Europe, propelled by rising healthcare expenditures and increased focus on rare disease treatment, holds a significant share of the global pharmaceutical market. Meanwhile, the Asia Pacific region is emerging as the fastest-growing market, driven by expanding healthcare access, favorable government policies, and increasing pharmaceutical manufacturing capabilities in China, India, and Japan.

With global healthcare trends shifting towards personalized medicine and biopharmaceutical innovations, pharmaceutical giants are actively engaging in mergers, acquisitions, and strategic alliances to strengthen their foothold in the market. Emerging technologies, such as mRNA-based therapeutics, gene editing, and cell therapy, are redefining treatment paradigms, offering promising opportunities for industry players. As the pharmaceutical landscape continues to evolve, companies are prioritizing agility, innovation, and digital transformation to stay ahead in a competitive environment.

Major Market Players Included in This Report Are:
• Pfizer Inc.
• Johnson & Johnson
• Novartis AG
• Merck & Co., Inc.
• Roche Holding AG
• Sanofi S.A.
• GlaxoSmithKline plc
• Bristol-Myers Squibb Company
• AbbVie Inc.
• AstraZeneca plc
• Eli Lilly and Company
• Amgen Inc.
• Bayer AG
• Takeda Pharmaceutical Company Limited
• Gilead Sciences, Inc.

The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Molecule Type:
• Small Molecules
• Biologics

By Product:
• Prescription Drugs
• Over-the-Counter (OTC) Drugs

By Type:
• Branded Drugs
• Generic Drugs

By Disease:
• Cardiovascular Diseases
• Oncology
• Neurological Disorders
• Infectious Diseases
• Diabetes
• Respiratory Diseases
• Others

By Age Group:
• Pediatric
• Adults
• Geriatric

By Route of Administration:
• Oral
• Injectable
• Topical
• Others

By Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Region:

North America:
• U.S.
• Canada

Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America:
• Brazil
• Mexico

Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of MEA

Years Considered for the Study:
• Historical Year – 2022, 2023
• Base Year – 2023
• Forecast Period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecasts for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level breakdowns of major regions.
• Competitive landscape with strategic insights into key industry players.
• In-depth evaluation of business strategies and recommendations for future market expansion.
• Supply and demand chain analysis to provide a 360-degree market perspective.

Table of Contents

285 Pages
Chapter 1. Global Pharmaceutical Market Executive Summary
1.1. Global Pharmaceutical Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Molecule Type
1.3.2. By Product
1.3.3. By Type
1.3.4. By Disease
1.3.5. By Age Group
1.3.6. By Route of Administration
1.3.7. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Pharmaceutical Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Pharmaceutical Market Dynamics
3.1. Market Drivers
3.1.1. Rapid Technological Advancements and R&D Investments
3.1.2. Increasing Prevalence of Chronic Diseases
3.1.3. Growing Demand for Personalized and Targeted Therapies
3.2. Market Challenges
3.2.1. High Drug Development and Manufacturing Costs
3.2.2. Stringent Regulatory Requirements and Pricing Pressures
3.3. Market Opportunities
3.3.1. Innovations in Biologics and Biosimilars
3.3.2. Expansion into Emerging Markets
3.3.3. Advancements in AI-Driven Drug Discovery
Chapter 4. Global Pharmaceutical Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Pharmaceutical Market Size & Forecasts by Molecule Type 2022-2032
5.1. Segment Dashboard
5.2. Global Pharmaceutical Market: Molecule Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Small Molecules
5.2.2. Biologics
Chapter 6. Global Pharmaceutical Market Size & Forecasts by Product 2022-2032
6.1. Segment Dashboard
6.2. Global Pharmaceutical Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Prescription Drugs
6.2.2. Over-the-Counter (OTC) Drugs
Chapter 7. Global Pharmaceutical Market Size & Forecasts by Type 2022-2032
7.1. Segment Dashboard
7.2. Global Pharmaceutical Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Branded Drugs
7.2.2. Generic Drugs
Chapter 8. Global Pharmaceutical Market Size & Forecasts by Disease 2022-2032
8.1. Segment Dashboard
8.2. Global Pharmaceutical Market: Disease Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Cardiovascular Diseases
8.2.2. Oncology
8.2.3. Neurological Disorders
8.2.4. Infectious Diseases
8.2.5. Diabetes
8.2.6. Respiratory Diseases
8.2.7. Others
Chapter 9. Global Pharmaceutical Market Size & Forecasts by Age Group 2022-2032
9.1. Segment Dashboard
9.2. Global Pharmaceutical Market: Age Group Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Pediatric
9.2.2. Adults
9.2.3. Geriatric
Chapter 10. Global Pharmaceutical Market Size & Forecasts by Route of Administration 2022-2032
10.1. Segment Dashboard
10.2. Global Pharmaceutical Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
10.2.1. Oral
10.2.2. Injectable
10.2.3. Topical
10.2.4. Others
Chapter 11. Global Pharmaceutical Market Size & Forecasts by Distribution Channel 2022-2032
11.1. Segment Dashboard
11.2. Global Pharmaceutical Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
11.2.1. Retail Pharmacies
11.2.2. Hospital Pharmacies
11.2.3. Online Pharmacies
Chapter 12. Global Pharmaceutical Market Size & Forecasts by Region 2022-2032
12.1. North America Pharmaceutical Market
12.1.1. U.S. Pharmaceutical Market
12.1.1.1. Molecule Type Breakdown Size & Forecasts, 2022-2032
12.1.1.2. Product Breakdown Size & Forecasts, 2022-2032
12.1.2. Canada Pharmaceutical Market
12.2. Europe Pharmaceutical Market
12.2.1. U.K. Pharmaceutical Market
12.2.2. Germany Pharmaceutical Market
12.2.3. France Pharmaceutical Market
12.2.4. Spain Pharmaceutical Market
12.2.5. Italy Pharmaceutical Market
12.2.6. Rest of Europe Pharmaceutical Market
12.3. Asia-Pacific Pharmaceutical Market
12.3.1. China Pharmaceutical Market
12.3.2. India Pharmaceutical Market
12.3.3. Japan Pharmaceutical Market
12.3.4. Australia Pharmaceutical Market
12.3.5. South Korea Pharmaceutical Market
12.3.6. Rest of Asia-Pacific Pharmaceutical Market
12.4. Latin America Pharmaceutical Market
12.4.1. Brazil Pharmaceutical Market
12.4.2. Mexico Pharmaceutical Market
12.4.3. Rest of Latin America Pharmaceutical Market
12.5. Middle East & Africa Pharmaceutical Market
12.5.1. Saudi Arabia Pharmaceutical Market
12.5.2. South Africa Pharmaceutical Market
12.5.3. Rest of MEA Pharmaceutical Market
Chapter 13. Competitive Intelligence
13.1. Key Company SWOT Analysis
13.1.1. Pfizer Inc.
13.1.2. Johnson & Johnson
13.1.3. Novartis AG
13.2. Top Market Strategies
13.3. Company Profiles
13.3.1. Pfizer Inc.
13.3.1.1. Key Information
13.3.1.2. Overview
13.3.1.3. Financial (Subject to Data Availability)
13.3.1.4. Product Summary
13.3.1.5. Market Strategies
13.3.2. Johnson & Johnson
13.3.3. Novartis AG
13.3.4. Merck & Co., Inc.
13.3.5. Roche Holding AG
13.3.6. Sanofi S.A.
13.3.7. GlaxoSmithKline plc
13.3.8. Bristol-Myers Squibb Company
13.3.9. AbbVie Inc.
13.3.10. AstraZeneca plc
13.3.11. Eli Lilly and Company
13.3.12. Amgen Inc.
13.3.13. Bayer AG
13.3.14. Takeda Pharmaceutical Company Limited
13.3.15. Gilead Sciences, Inc.
Chapter 14. Research Process
14.1. Research Process
14.1.1. Data Mining
14.1.2. Analysis
14.1.3. Market Estimation
14.1.4. Validation
14.1.5. Publishing
14.2. Research Attributes
List of Tables
TABLE 1. Global Pharmaceutical Market, Report Scope
TABLE 2. Global Pharmaceutical Market Estimates & Forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Pharmaceutical Market Estimates & Forecasts by Molecule Type 2022-2032 (USD Billion)
TABLE 4. Global Pharmaceutical Market Estimates & Forecasts by Product 2022-2032 (USD Billion)
TABLE 5. Global Pharmaceutical Market Estimates & Forecasts by Type 2022-2032 (USD Billion)
TABLE 6. Global Pharmaceutical Market Estimates & Forecasts by Disease 2022-2032 (USD Billion)
TABLE 7. Global Pharmaceutical Market Estimates & Forecasts by Age Group 2022-2032 (USD Billion)
TABLE 8. Global Pharmaceutical Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 9. Global Pharmaceutical Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 10. Global Pharmaceutical Market by Region, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 11. U.S. Pharmaceutical Market Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 12. U.S. Pharmaceutical Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
TABLE 13. Canada Pharmaceutical Market Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 14. Canada Pharmaceutical Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
…
(This list is not complete; the final report does contain more than 100 tables. The list may be updated in the final deliverable.)
List of Figures
FIGURE 1. Global Pharmaceutical Market, Research Methodology
FIGURE 2. Global Pharmaceutical Market, Market Estimation Techniques
FIGURE 3. Global Market Size Estimates & Forecast Methods.
FIGURE 4. Global Pharmaceutical Market, Key Trends 2023
FIGURE 5. Global Pharmaceutical Market, Growth Prospects 2022-2032
FIGURE 6. Global Pharmaceutical Market, Porter’s 5 Force Model
FIGURE 7. Global Pharmaceutical Market, PESTEL Analysis
FIGURE 8. Global Pharmaceutical Market, Value Chain Analysis
FIGURE 9. Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIGURE 10. Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIGURE 11. Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIGURE 12. Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIGURE 13. Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIGURE 14. Global Pharmaceutical Market, Regional Snapshot 2022 & 2032
FIGURE 15. North America Pharmaceutical Market 2022 & 2032 (USD Billion)
FIGURE 16. Europe Pharmaceutical Market 2022 & 2032 (USD Billion)
FIGURE 17. Asia-Pacific Pharmaceutical Market 2022 & 2032 (USD Billion)
FIGURE 18. Latin America Pharmaceutical Market 2022 & 2032 (USD Billion)
FIGURE 19. Middle East & Africa Pharmaceutical Market 2022 & 2032 (USD Billion)
FIGURE 20. Global Pharmaceutical Market, Company Market Share Analysis (2023)
…
(This list is not complete; the final report does contain more than 50 figures. The list may be updated in the final deliverable.)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us